MedPath

Sleep Apnea Study in Adults Using DreamPort-Eclipse and a Traditional Nasal Mask

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: ResMed P-10 mask
Device: Eclipse novel CPAP mask
Registration Number
NCT05818540
Lead Sponsor
Bleep, LLC
Brief Summary

The Randomized Controlled Trial of Bleep DreamPort-Eclipse Study is a two-arm, randomized, prospective, non-blinded study to assess the effectiveness of the novel CPAP human interface design to improve leak, AHI, and pressure compared to a traditional nasal mask.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
173
Inclusion Criteria

• Male or female ≥18 years old who are impacted by obstructive sleep apnea and currently are familiar with a CPAP device

Exclusion Criteria
  • Any medical or behavioral conditions that would compromise subject safety
  • Under the age of 18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Traditional CPAP maskResMed P-10 maskHuman subjects will use the ResMed P-10 CPAP interface for 60 days for a total of 6 hours per night.
Eclipse novel maskEclipse novel CPAP maskHuman subjects will use the Eclipse CPAP interface for 60 days for a total of 6 hours per night.
Primary Outcome Measures
NameTimeMethod
Apnea-Hypopnea Index (AHI)60 days

The Apnea-Hypopnea Index or Apnoea-Hypopnoea Index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. The apneas (pauses in breathing) must last for at least 10 seconds and be associated with a decrease in blood oxygenation. For OSA treatment, we are looking to see AHI decrease to \<5.

Leak60 days

Leak can be caused by several issues- having the wrong mask size or type, the mask not being assembled or fitted correctly, or parts being worn out and needing replacement. The acceptable leak rate is up to 24 litres per minute. Anything below this means the patient is still getting the full benefits of therapy.

CPAP Device Pressure60 days

CPAP device pressure is expected to decrease with decrease leak with the novel mask.

Secondary Outcome Measures
NameTimeMethod
Participant satisfaction with the mask choice:60 days

Survey title: Bleep Sleep (BSL)-SNAP-003 Participant Survey

Satisfaction will be based on a participant questionnaire in which they indicate their overall satisfaction with the mask they are assigned.Lower score indicates higher patient satisfaction. Scale is as follows: Strongly disagree, Disagree, Neither agree or disagree, Agree, Strongly Agree.

Mask Acceptance60 days

Mask acceptance will be defined by continued use versus discontinued use

Trial Locations

Locations (1)

Sleep Centers of Middle Tennessee

🇺🇸

Murfreesboro, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath